We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Insights Into Emerson Electric (EMR) Q3: Wall Street Projections for Key Metrics
Read MoreHide Full Article
The upcoming report from Emerson Electric (EMR - Free Report) is expected to reveal quarterly earnings of $1.68 per share, indicating an increase of 10.5% compared to the year-ago period. Analysts forecast revenues of $4.79 billion, representing an increase of 5.3% year over year.
Over the last 30 days, there has been a downward revision of 0.1% in the consensus EPS estimate for the quarter, leading to its current level. This signifies the covering analysts' collective reconsideration of their initial forecasts over the course of this timeframe.
Before a company announces its earnings, it is essential to take into account any changes made to earnings estimates. This is a valuable factor in predicting the potential reactions of investors toward the stock. Empirical research has consistently shown a strong correlation between trends in earnings estimate revisions and the short-term price performance of a stock.
While it's common for investors to rely on consensus earnings and revenue estimates for assessing how the business may have performed during the quarter, exploring analysts' forecasts for key metrics can yield valuable insights.
That said, let's delve into the average estimates of some Emerson Electric metrics that Wall Street analysts commonly model and monitor.
Analysts expect 'Net Sales- Intelligent Devices- Total' to come in at $2.64 billion. The estimate points to a change of -15.6% from the year-ago quarter.
According to the collective judgment of analysts, 'Net Sales- Software & Systems- Control Systems & Software' should come in at $1.18 billion. The estimate points to a change of +9% from the year-ago quarter.
Based on the collective assessment of analysts, 'Net Sales- Intelligent Devices- Final Control' should arrive at $1.58 billion. The estimate suggests a change of +41.4% year over year.
Analysts' assessment points toward 'Net Sales- Software & Systems- Test & Measurement' reaching $413.56 million. The estimate points to a change of +14.6% from the year-ago quarter.
Analysts forecast 'Net Sales- Software & Systems- Total' to reach $1.59 billion. The estimate indicates a change of +10.4% from the prior-year quarter.
Shares of Emerson Electric have experienced a change of +4.5% in the past month compared to the -1.5% move of the Zacks S&P 500 composite. With a Zacks Rank #4 (Sell), EMR is expected to underperform the overall market in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .
View the Zacks #1 Rank List
Image: Bigstock
Insights Into Emerson Electric (EMR) Q3: Wall Street Projections for Key Metrics
The upcoming report from Emerson Electric (EMR - Free Report) is expected to reveal quarterly earnings of $1.68 per share, indicating an increase of 10.5% compared to the year-ago period. Analysts forecast revenues of $4.79 billion, representing an increase of 5.3% year over year.
Over the last 30 days, there has been a downward revision of 0.1% in the consensus EPS estimate for the quarter, leading to its current level. This signifies the covering analysts' collective reconsideration of their initial forecasts over the course of this timeframe.
Before a company announces its earnings, it is essential to take into account any changes made to earnings estimates. This is a valuable factor in predicting the potential reactions of investors toward the stock. Empirical research has consistently shown a strong correlation between trends in earnings estimate revisions and the short-term price performance of a stock.
While it's common for investors to rely on consensus earnings and revenue estimates for assessing how the business may have performed during the quarter, exploring analysts' forecasts for key metrics can yield valuable insights.
That said, let's delve into the average estimates of some Emerson Electric metrics that Wall Street analysts commonly model and monitor.
Analysts expect 'Net Sales- Intelligent Devices- Total' to come in at $2.64 billion. The estimate points to a change of -15.6% from the year-ago quarter.
According to the collective judgment of analysts, 'Net Sales- Software & Systems- Control Systems & Software' should come in at $1.18 billion. The estimate points to a change of +9% from the year-ago quarter.
Based on the collective assessment of analysts, 'Net Sales- Intelligent Devices- Final Control' should arrive at $1.58 billion. The estimate suggests a change of +41.4% year over year.
Analysts' assessment points toward 'Net Sales- Software & Systems- Test & Measurement' reaching $413.56 million. The estimate points to a change of +14.6% from the year-ago quarter.
Analysts forecast 'Net Sales- Software & Systems- Total' to reach $1.59 billion. The estimate indicates a change of +10.4% from the prior-year quarter.
View all Key Company Metrics for Emerson Electric here>>>Shares of Emerson Electric have experienced a change of +4.5% in the past month compared to the -1.5% move of the Zacks S&P 500 composite. With a Zacks Rank #4 (Sell), EMR is expected to underperform the overall market in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .